PAPER Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S,

Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Eur J Clin Pharmacol. 2013 Aug;69(8):1589-1597. PubMed: 23588564

PAPER Clarfield AM, Dwolatzky T

Exercise in Alzheimer disease: comment on "Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial".

JAMA Intern Med. 2013 May 27;173(10):901-2. PubMed: 23588877

PAPER Ando K, Brion JP, Stygelbout V, Suain V, Authelet M, Dedecker R, Chanut A, Lacor P, Lavaur J, Sazdovitch V, Rogaeva E, Potier MC, Duyckaerts C

Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains.

Acta Neuropathol. 2013 Jun;125(6):861-78. PubMed: 23589030

PAPER Pitkälä KH, Pöysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE

Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial.

JAMA Intern Med. 2013 May 27;173(10):894-901. PubMed: 23589097

PAPER Jeon AH, Böhm C, Chen F, Huo H, Ruan X, Ren CH, Ho K, Qamar S, Mathews PM, Fraser PE, Mount HT, St George-Hyslop P, Schmitt-Ulms G

Interactome analyses of mature γ-secretase complexes reveal distinct molecular environments of presenilin (PS) paralogs and preferential binding of signal peptide peptidase to PS2.

J Biol Chem. 2013 May 24;288(21):15352-66. PubMed: 23589300

Sylvain Lesne on The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

COMMENT I would like to point out what I believe constitutes misinterpretations/misconceptions related to oligomeric Aβ found in this article. In this report, the authors claimed to detect amyloid-β in brain lysates of APP transgenic J20 mice using the antibody 6

Society for Neuroscience Annual Meeting 2014

CONFERENCE 2014-11-15 00:00:00-2014-11-19 00:00:00 Washington, D.C. 15 &#x2013 19 November 2014 Neuroscience 2014 returns to Washington, DC. View Conference Website 1

American Neurological Association: 2013 Annual Meeting

CONFERENCE 2013-10-12 00:00:00-2013-10-14 00:00:00 Baltimore Marriott Waterfront, Baltimore, MD, U.S.A. 12 &#x2013 14 October 2013 View Conference Website 1

International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, 2013

CONFERENCE 2013-04-17 00:00:00-2013-04-17 00:00:00 International Conference Centre, Geneva, Switzerland 17 April 2013 Leading scientists will discuss new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy. An oral communication session will be open to young

International Congress on Vascular Dementia & The First Cognitive Impairment European Meeting, 2013

CONFERENCE 2013-10-17 00:00:00-2013-10-20 00:00:00 Athens, Greece 17 &#x2013 20 October 2013 The 8th International Congress on Vascular Dementia & The First Cognitive Impairment European Meeting is a niche meeting that will showcase new developments in the study of dementia. The goal of this highl

The Jerusalem Conference on Neuroplasticity and Cognitive Modifiability

CONFERENCE 2013-10-10 00:00:00-2013-10-13 00:00:00 Jerusalem, Israel 10 &#x2013 13 October 2013 Scientific advancements in conceptualization and technology make available new tools for professionals facing medical, psychological, educational, and societal problems facing human beings on a global scale

World Congress of Neurology 2013

CONFERENCE 2013-09-21 00:00:00-2013-09-26 00:00:00 Vienna, Austria 21 &#x2013 26 September 2013 Join leading neurologists at WCN 2013, the world’s biggest neurology event. The XXI World Congress of Neurology will feature a rich scientific programme, including the latest developments in clinical practi

Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum

CONFERENCE 2013-09-18 00:00:00-2013-09-20 00:00:00 Aspen Meadows Resort, Aspen, CO, U.S.A. 18 &#x2013 20 September 2013 Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologi

International Molecular Neurodegeneration Conference, 2013

CONFERENCE 2013-09-10 00:00:00-2013-09-12 00:00:00 Novotel Cannes Montfloury, Cannes, France 10 &#x2013 12 September 2013 The 2013 conference will see world-renowned experts present cutting-edge research that, in combination with poster presentations and short talks, will provide the latest updates on

Vas-Cog Congress, 2013

CONFERENCE 2013-06-25 00:00:00-2013-06-28 00:00:00 Toronto, Ontario, Canada 25 &#x2013 28 June 2013 The VASCOG Congress program includes a series of sessions, meetings and workshops designed to promote the discussion and exchange of ideas. Participants represent a broad spectrum of academic discipline